Trials / Terminated
TerminatedNCT01798602
Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Canadian Critical Care Trials Group · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The CHAT Pilot Trial is designed to compare rosuvastatin against placebo in patients with suspected H1N1. The pilot study will assess the feasibility of our clinical protocols, and study procedures.
Detailed description
This trial is a pilot study to assess the feasibility and acceptability of a double blind randomized controlled trial (RCT) evaluating the efficacy of rosuvastatin as adjuvant therapy for H1N1 influenza
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin or identical placebo | Tablet crushed for administration via feeding tube |
| DRUG | Placebo | Identical placebo for rosuvastatin |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-05-01
- Completion
- 2010-08-01
- First posted
- 2013-02-26
- Last updated
- 2013-02-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01798602. Inclusion in this directory is not an endorsement.